EPITOPEA APS NUF
Operating
Skal drive klinisk utvikling av farmasøytiske behandlinger mot kreft,
samt andre aktiviteter relatert til dette.
Links
Organization
- CEO
- Years since formation
- 1 year
- since Jul 3, 2025
- Type
- Norwegian division of foreign business enterprise
- VAT registered
- No
- Number of employees
- 0
Financials
- Annual total result 2025
- -2,726,374
- NOK
- Total equity 2025
- -2,726,374
- NOK
Last update: Jun 13, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Information about the Company in the Home Country | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Jul 22, 2025
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -2,726,374 |
Total assets | 1,317,925 |
Total liabilities | 4,044,299 |
Total equity | -2,726,374 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 3,498,675 |
Operating result | -3,498,675 |
Financial income/costs | 3,324 |
Profit before tax | -3,495,351 |
Total tax & extraordinary income/cost | -768,977 |
Annual Total Result | -2,726,374 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 768,977 |
Total current assets | 548,948 |
Total assets | 1,317,925 |
Short term debt | 4,044,299 |
Long term debt | 0 |
Total liabilities | 4,044,299 |
Contributed capital | 0 |
Retained earnings | -2,726,374 |
Total equity | -2,726,374 |
Total equity and liabilities | 1,317,925 |
Classification
Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises